Vaccines against Allergies

  • Rudolf Valenta
  • Robert L. Coffman
Book

Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 352)

Table of contents

  1. Front Matter
    Pages i-xi
    PDF
  2. Immunological Approaches for Tolerance Induction in Allergy
    Melanie L. Conrad, Harald Renz, Kurt Blaser
    Pages 1-26
  3. Clinical Experience with Recombinant Molecules for Allergy Vaccination
    Oliver Cromwell, Verena Niederberger, Friedrich Horak, Helmut Fiebig
    Pages 27-42
  4. Allergen-Specific Immunotherapy with Recombinant Allergens
    G. Pauli, Hans-Jørgen Malling
    Pages 43-54
  5. Vaccine Approaches for Food Allergy
    Philip Rancitelli, Alison Hofmann, A. Wesley Burks
    Pages 55-69
  6. Intralymphatic Immunotherapy: From the Rationale to Human Applications
    Gabriela Senti, Pål Johansen, Thomas M. Kündig
    Pages 71-84
  7. Induction of Allergen-Specific Tolerance via Mucosal Routes
    Laurent Mascarell, Aline Zimmer, Laurence Van Overtvelt, Sophie Tourdot, Philippe Moingeon
    Pages 85-105
  8. T Cell Epitope-Based Allergy Vaccines
    Mark Larché
    Pages 107-119
  9. Allergen-Specific Immunotherapy: Towards Combination Vaccines for Allergic and Infectious Diseases
    Johanna Edlmayr, Katarzyna Niespodziana, Margarete Focke-Tejkl, Birgit Linhart, Rudolf Valenta
    Pages 121-140
  10. Passive Immunization with Allergen-Specific Antibodies
    Sabine Flicker, Elisabeth Gadermaier, Christoph Madritsch, Rudolf Valenta
    Pages 141-159
  11. Cell-Based Therapy in Allergy
    Ulrike Baranyi, Martina Gattringer, Rudolf Valenta, Thomas Wekerle
    Pages 161-179
  12. Back Matter
    Pages 181-182
    PDF

About this book

Introduction

The pathomechanisms of allergy are quite well investigated and the disease-causing allergens are characterized in great detail down to their molecular structures. We are thus beginning to see several new strategies for allergen-specific immunotherapy on the horizon, several of which are summarized in this issue. It thus seems that hundred years after the first experimental attempts to “desensitize” hayfever patients we are now capable of developing powerful and rational forms of immunotherapy which hold promise for curing allergy sufferers and eventually may allow real prophylactic vaccination against allergy. It is thus quite possible that allergy may become eradicated similar as certain forms of infectious diseases through vaccination.

Keywords

IgE-mediated allergy allergen specific immunotherapy diet-specific tolerance promotion engineered food proteins food allergy inflammatory immune response recombinant DNA technology recombinant allergens regulatory T lymphocyte synthetic peptides tolerance induction

Editors and affiliations

  • Rudolf Valenta
    • 1
  • Robert L. Coffman
    • 2
  1. 1.Christian Doppler Laboratory for AllergyMedical University of ViennaViennaAustria
  2. 2.Dynavax TechnologiesBerkeleyUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-20054-0
  • Copyright Information Springer-Verlag Berlin Heidelberg 2011
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-3-642-20053-3
  • Online ISBN 978-3-642-20054-0
  • Series Print ISSN 0070-217X
  • Series Online ISSN 2196-9965
  • About this book